Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.

× No keyword cloud information.

4 in total

1. Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro.

Authors: J S Sebolt; S V Scavone; C D Pinter; K L Hamelehle; D D Von Hoff; R C Jackson
Journal: Cancer Res Date: 1987-08-15 Impact factor: 12.701

2. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

Authors: P LoRusso; A J Wozniak; L Polin; D Capps; W R Leopold; L M Werbel; L Biernat; M E Dan; T H Corbett
Journal: Cancer Res Date: 1990-08-15 Impact factor: 12.701

3. Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.

Authors: A A Adjei; M Charron; E K Rowinsky; P A Svingen; J Miller; J M Reid; J Sebolt-Leopold; M M Ames; S H Kaufmann
Journal: Clin Cancer Res Date: 1998-03 Impact factor: 12.531

4. Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.

Authors: E K Rowinsky; D A Noe; L B Grochow; S E Sartorious; M K Bowling; T L Chen; B G Lubejko; S H Kaufmann; R C Donehower
Journal: J Clin Oncol Date: 1995-08 Impact factor: 44.544

4 in total

1 in total

1. Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.

Authors: Bhuvaneswari Ramaswamy; Ewa Mrozek; John Philip Kuebler; Tanios Bekaii-Saab; Eric H Kraut
Journal: Invest New Drugs Date: 2009-10-21 Impact factor: 3.850

1 in total